Clinical Study Of Allergic Rhinitis (Iltehab e Anaf Hissasi) And Its Management With Unani Medicine
Not Applicable
- Conditions
- Health Condition 1: J00- Acute nasopharyngitis [common cold]
- Registration Number
- CTRI/2023/01/048785
- Lead Sponsor
- PG Department of Moalijat General Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with following sign and symptoms suggesting the diagnosis of Allergic Rhinitis
a. Nasal Discharge
b. Sneezing
c. Nasal Obstruction
d. Dull Headache
f. Nasal itching
Exclusion Criteria
Age <15and >65 years were excluded from the study
Pregnant women with Allergic Rhinitis
Known cases of coronary artery disease, ischemic heart disease and myocardial infarction
Patients with Pulmonary disease such as Allergic Bronchial Asthma and other allergic systemic disorders
Deviated Nasal Septum and Sinusitis
Patients with other ENT diseases were exclude
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome depends upon before and after the treatment of low Immunoglobulin E and Absolute Eosinophill Count levels within 6 weeksTimepoint: Primary outcome depends upon before and after the treatment of low Immunoglobulin E and Absolute Eosinophill Count levels within 6 weeks
- Secondary Outcome Measures
Name Time Method Primary outcome depends upon before and after the treatment of low Immunoglobulin E and Absolute Eosinophil Count levelsTimepoint: Primary outcome depends upon before and after the treatment of low Immunoglobulin E and Absolute Eosinophil count levels;Secondary outcome will be arelief of symptoms of allergic rhinitis after 6weeks of medicine givenTimepoint: Secondary outcome will be relief of symptoms of allergic rhinitis after 6weeks of medicine given